Allergy and Immunology
Matthew Germinaro, MD
Independent provider
Sees patients age 18 and up
Penn Allergy and Immunology University City

About me

  • Adjunct Assistant Professor of Medicine (Pulmonary, Allergy and Critical Care)

Education and training

  • Medical School: Temple University School of Medicine
  • Residency: University of Colorado Medical Center
  • Fellowship: University of Colorado Medical Center

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Germinaro is an independent physician who is not employed by Penn Medicine.

Qualifications and experience

My research

Brian G Feagan, Bruce E Sands, William J Sandborn, Matthew Germinaro, Marion Vetter, Jie Shao, Shihong Sheng, Jewel Johanns, Julián Panés Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial , Lancet Gastroenterol Hepatol, 8(4): 2023,307-320


Sandborn WJ, D'Haens GR, Reinisch W, Panés J, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG; GALAXI-1 Investigators. Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. , Gastroenterology, 162(6): 2022,1650-1664.e8.


Dreskin SC, Germinaro M, Reinhold D, Chen X, Vickery BP, Kulis M, Burks AW, Negi SS, Braun W, Chambliss J, Eglite S, McNulty CMG. IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy. , Pediatr Allergy Immunol , 30(8): 2019,817-823


Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, Bateman ED, Hoyte FCL, Germinaro M. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps. , J Allergy Clin Immunol Pract, 7(2): 2019,589-596.e3


Bateman ED, Djukanovic R, Castro M, Canvin J, Germinaro M, Noble R, Garin M, Buhl R. Predicting Responders to Reslizumab After 16 Weeks of Treatment Using an Algorithm Derived From Clinical Studies of Patients with Severe Eosinophilic Asthma. , Am J Respir Crit Care Med, 199(4): 2019,489-495


Brusselle G, Germinaro M, Weiss S, Zangrilli J. Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils. , Pulm Pharmacol Ther, 43: 2017,39-45


Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M. Reslizumab for Inadequately Controlled Asthma with Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. , CHEST, 150(4): 2016,789-798


Germinaro, M., Reynolds, P., Knight, V., Alam, R. Association of B-cell activating factor receptor deficiency with the P21R polymorphism and common variable immunodeficiency. , Ann Allergy Asthma Immunol, 115(1): 2015,82-83


Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A, Malhotra V, Sood N, Midda V, Monga DK, Kokkinakis DM, Monga SP Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. , Neoplasia, 8(4): 2006,279-289


Monga SP, Micsenyi A, Germinaro M, Apte U, Bell A. beta-Catenin regulation during matrigel-induced rat hepatocyte differentiation. , Cell and Tissue Research, 323(1): 2006,71-79